Download >>> https://byltly.com/283eei
The Indian Pharmacopoeia, developed by the directorate general of Indian standards under the administration of the ministry of chemicals and fertilizers, is a compendium of specifications for drugs in India. The pharmaceutical Industry in India is one of the primary contributors to health care providers in both rural and urban areas. The industry has accelerated medication introduction with an underlying motive to meet public demands through study, research and introduce new medications into market. Government of India is very focused on the expansion of Indian pharmaceutical industry and has introduced policies to encourage research and development, training of scientists, provide incentives for marketing, innovation and exports. The Indian Pharmacopoeia Commission (IPC) was constituted in 1937 by the Drugs Act, which is considered as an act of empowering the central government to formulate rules for listing various drugs. The principal motivation behind the creation of the IPC was to promote uniformity in drug indication, ingredients and doses. With time Pharmacopoeia Commission has added more responsibilities such as developing a new method to test a particular medication or researching a new drug or identifying a traditional medicine. The IPC is now the largest committee for drug vetting in India, with about 20 people working on various projects. The IPC, as a statutory body under the ministry of chemicals and fertilizers reviews and reviews existing formulations of drugs and gives recommendations for extensive updates and changes. IPC, as a regulatory body reviews all new patent applications pertaining to drugs which were submitted by pharmaceutical industry. The Centre for Pharmaceutical Education and Research (CEPR) under the Ministry of Science & Technology helps IPC in carrying out its work. The IPC also develops specifications for new drugs, provides clearances to companies before marketing the same in India or abroad etc. Indian government is in the process of providing recognition to Indian Pharmacopoeia in various international forums. India is associate member of the International Council for Harmonisation (ICH) and has acceded to the Convention on control of narcotic drugs. Recognition is being taken up by the government with United States, European Union, World Health Organization, etc. for easy recognition of Indian standards. PMI 1 - The international pharmacopoeia 1 is the international standard for labeling of medicines. The Indian pharmacopoeia 1 contains specifications to classify drugs by therapeutic class, route of administration, dosage form and chemical structure. PMI 2 - The international pharmacopoeia 2 is the international standard for labeling of medicines. The Indian pharmacopoeia 1 contains specifications to classify drugs by therapeutic class, route of administration, dosage form and chemical structure. PMI 3 - The international pharmacopoeia 3 is the international standard for labeling of medicines. The Indian pharmacopoeia 1 contains specifications to classify drugs by therapeutic class, route of administration, dosage form and chemical structure. cfa1e77820
Comentarios